Health Canada NHP Site Licence Renewal Process and Requirements 

---

---

All Natural Health Product (NHP) site licence holders in Canada must renew their licence in accordance with the Natural Health Products Regulations. Although the renewal term varies by licence and is assigned directly by Health Canada, the obligation remains consistent across all sites: confirm continued compliance with Part 3 Good Manufacturing Practices (GMP) and keep Health Canada’s site and foreign-site information current for all regulated activities.  

As site licence holders move toward their renewal date, the process shifts from a routine administrative requirement to a structured review of how the quality system has performed since the previous term. This includes validating site information, confirming GMP evidence, reviewing foreign-site documentation, and completing the Harmonized Site Licence and FSRN Application Form (webSLA) to reflect the present state of operations. In this article, we will examine the renewal requirements, the documentation expected by Health Canada, the review process, common pitfalls, and the conditions under which a site licence may be refused or suspended. 

What Is an NHP Site Licence and Why Renewal Matters 

An NHP site licence authorizes a physical location in Canada to conduct activities related to product manufacturing, packaging, labelling, and importation. Each licence is tied to a specific site for which it was issued, rather than the company as a whole. As such, every facility performing regulated activities must hold its own site licence that reflects the activities carried out at that location. For example, some sites may be licensed solely to import NHPs, while others may be licensed to manufacture, package, and label products. The activities performed at each site must correspond to the information listed on the issued site licence. 

Ongoing Responsibilities for NHP Site Licence Holders 

Regulatory obligations do not end once a site licence is granted. Site licence holders are expected to operate in alignment with NHP GMP and maintain ongoing compliance with the Natural Health Products Regulations. To support this, Health Canada requires that all site licence holders renew their licence on a recurring basis. During renewal, licence holders must demonstrate how GMP requirements are applied in daily operations and provide evidence that their quality system remains active, current, and reflective of actual site practice. 

Why NHP Site Licence Renewal Is Critical 

Renewal serves as a critical confirmation step. Through recurring renewals, Health Canada verifies that the site continues to operate according to its documented quality system, that the Quality Assurance Person (QAP) maintains oversight of all regulated activities, and that production controls, testing practices, and supply-chain arrangements remain accurate. Renewal also allows Health Canada to assess whether the GMP evidence submitted with the application aligns with present-day operations. 

Consequences of an Expired NHP Site Licence 

If a renewal lapses, the site can no longer legally manufacture, package, label, import, or release NHPs for sale in Canada. Renewal is therefore directly linked to business continuity and the site’s ongoing fulfillment of regulatory expectations and requirements.  

Health Canada NHP Site Licence Renewal Frequency and Process Overview 

Site licence renewal frequency is based on how long the licence has been held. Health Canada’s Site Licensing Guidance Document describes a staged cycle: annual renewals during the first three years, renewals every two years once the licence has been held for at least three years but less than nine years, and renewals every three years once the licence has been held for nine years or more. 

Health Canada requires licence holders to submit their renewal package at least 30 days before the licence expiry date. Although the renewal process mirrors the structure of the original site licence application, the emphasis shifts toward demonstrating how the site’s systems and records function in practice. Renewal is not limited to confirming that written procedures are in place; rather, the focus is on showing that those procedures are actively applied, properly maintained, and supported by current evidence. 

The following sections describe the renewal fees, the administrative and technical review stages, and the outcomes that Health Canada may issue once the review is complete. 

NHP Site Licence Renewal Fees 

There are currently no fees associated with NHP site licence renewal. Although Health Canada has consulted on a future cost-recovery framework that would introduce fees for site licences, these fees have not been implemented and are not in force under the Natural Health Products Regulations. Until a formal fee order is published in the Canada Gazette, Part II, site licence renewals continue to be processed without payment requirements. Licence holders should monitor Health Canada updates, as future regulatory changes may introduce renewal fees at a later date. 

Health Canada’s NHP Site Licence Renewal Process 

Health Canada follows a structured renewal process that begins with an administrative screening and progresses into a detailed technical review. Understanding how these stages unfold helps licence holders anticipate common questions and prepare supporting documents that align with regulatory expectations. 

Administrative Screening for NHP Renewals 

The administrative screening stage involves confirming that the webSLA submission is complete, that required attestations and signatory sections are completed, and that the activities and site details entered in the application align with the supporting documentation. Even minor inconsistencies, such as mismatched addresses or outdated contact information, often lead to requests for additional clarifications in the form of a Screening Deficiency Notice (for administrative details) or an Information Request Notice (IRN). Because these requests include firm deadlines, addressing accuracy before submission helps reduce interruptions to the review.

Technical Review of GMP Compliance 

Once the submission passes administrative screening, Health Canada conducts a technical review of the site’s GMP controls, documentation, and records. During this stage, reviewers assess whether the quality system is active and whether procedures correspond to actual practices at the site. This evaluation aligns with the core principles often described as the 4 Ps of GMP: People, Premises, Processes, and Products.

Health Canada examines whether People remain trained, qualified, and supported by clear responsibilities; whether Premises and equipment are maintained in a controlled state; whether Processes such as manufacturing, testing, packaging, labelling, and deviation management are consistently followed; and whether Products are managed with complete traceability and released by an authorized QAP.

To verify this alignment, reviewers may request documents such as standard operating procedures (SOPs), deviation and investigation records, calibration and maintenance certificates, or validation summaries. These records help demonstrate that GMP principles are embedded in daily operations and that the site continues to meet the regulatory requirements.

Information Request Notices (IRNs) for Site Licence Renewal 

If a concern arises or clarification is needed, Health Canada may issue a request for additional information to obtain evidence or explanations regarding how specific activities are being managed. IRNs are issued with a defined response deadline, typically 15 business days. The notice outlines the specific clarification or evidence required, and the renewal cannot progress until a complete response is submitted. If the response is incomplete or not provided within the allotted timeframe, Health Canada may proceed with a refusal. 

Extension requests are considered on a case-by-case basis, but applicants should be aware that extensions may place the renewal outside Health Canada’s service standards. For this reason, sites benefit from maintaining current documentation throughout the licensing cycle and ensuring that renewal submissions are complete before filing. 

Renewal Decision Outcomes 

If the renewal package demonstrates that the site continues to meet GMP requirements, Health Canada will issue an updated site licence with a new expiry date. If documentation gaps remain or if the evidence does not fully support the activities listed on the licence, Health Canada may limit certain activities or request additional information before proceeding. In situations where significant deficiencies or risks are identified, the agency may refuse the renewal or suspend the existing licence until the identified issues are resolved. 

Site License Renewal Timeline 

Health Canada applies defined service standards to NHP site licence renewals, and the review timeline depends on the type of GMP evidence included in the submission.  

These service standards are based on Health Canada’s internal guidance and are expressed in business days; however, they are not guaranteed, and many licence holders experience longer review times when files are complex, when additional clarifications are needed, or when volume of renewals affect review capacity. 

Site Licence Renewal Eligibility and Requirements 

Before preparing a renewal package, licence holders must determine whether their current site information, operational activities, and quality oversight still align with the licence on file. In some cases, updates are required before a renewal can proceed. The following considerations help clarify when a renewal is appropriate and when an amendment or notification is needed instead. 

Administrative Criteria for Renewal 

Health Canada will not process a renewal if core administrative requirements are not met. This includes using the correct version of the webSLA and ensuring that QAP and regulatory contact information is current. Renewal may also be delayed when the details on the existing site licence no longer reflect the site’s ownership, address, or scope of activities. Changes of this nature require a site licence amendment before the renewal can be submitted, while minor updates that do not affect the licence scope can generally be addressed through a notification. 

If key site licence details have changed, such as ownership, site address, or the licensed scope of activities, an amendment should be submitted prior to the licence renewal. Licence holders should not implement activities relating to an amendment until Health Canada has issued the amended licence.  

For changes that fall within Health Canada’s notification categories, such as updates to contact information or QAP information, notifications must be submitted within 60 calendar days of the change.  

Health Canada also recommends that amendment and notification applications be submitted at least 65 business days before the site licence expiry date or after the licence expiry date for which a renewal has been received, to reduce processing delays that can impact site licence renewals. 

Operational Criteria for Renewal 

Operational eligibility depends on whether the site continues to conduct the activities listed on its licence. If manufacturing, packaging, labelling, or importation activities have ceased, or if the facility has restructured operations in a way that changes the licensed activities, Health Canada may require an amendment to align the site licence with current operations. Failing to update these details before renewal can result in discrepancies that trigger requests for additional clarifications or delays in the technical review. Ensuring that the licence accurately reflects present-day operations strengthens the renewal package and supports a clear regulatory record. 

Ensuring Readiness Before Submission 

Validating both administrative and operational requirements well in advance of the renewal date helps licence holders determine whether a renewal, amendment, or notification is required. Sites that resolve changes early and maintain alignment between their documented activities and the licence on file are better positioned for a smooth review. Addressing these elements ahead of time reduces avoidable interruptions and supports a complete, accurate, and timely renewal submission. 

Preparing for a Site Licence Renewal – webSLA & Related Requirements  

The webSLA serves as the administrative foundation of the renewal submission. Licence holders must complete the most recent version of the form, select “Renewal,” and provide key details such as the legal entity name, business number, operating address, and any alternate business names. The form must also identify the QAP and primary regulatory contact with direct email and telephone information, as Health Canada relies on these channels for renewal updates and follow-up questions. Applicants are required to list all activities conducted at the site, including manufacturing, packaging, labelling, importation, distribution, and storage, and these activities must align with the GMP evidence provided in the renewal package. 

Licence holders must also disclose any material changes since the previous term, such as adjustments to ownership, new equipment, updates to the facility layout, changes to quality personnel, or shifts in the scope of work. Clear and accurate disclosure demonstrates ongoing oversight and assists Health Canada in understanding how the site has evolved during the licensing period. 

Quality Assurance Documentation for Renewal 

The quality assurance component of the renewal should demonstrate ongoing oversight of GMP performance throughout the licensing cycle. Depending on the evidence pathway used, this may include a QAR supported by records that reflect how the quality system performs in practice, such as deviation and investigation outputs, Corrective and Preventive Actions (CAPA) activity, change control decisions, complaint handling, recall readiness, and internal audit follow-up. This evidence helps Health Canada assess whether quality oversight is active, current, and consistent with the activities authorized under the site licence. 

Training records and training matrices must accompany the submission to demonstrate that personnel remain qualified for their roles, and that retraining occurs when procedures or responsibilities change. Importers must also provide evidence of supplier oversight and foreign-site monitoring, such as GMP review summaries, recent audit reports, or updates to qualification status. Collectively, these documents show how the site maintains oversight of its operations and the broader supply chain. 

Site Information Requirements 

The site information package allows Health Canada to assess the facility layout and the environmental controls that support NHP activities. Updated floor plans illustrating material and personnel flow, as well as segregation of ingredients or high-risk materials, help reviewers evaluate how the site manages cross-contamination risks. Storage conditions should be described in sufficient detail to demonstrate control of conditions that may affect quality, including defined storage ranges, evidence of monitoring, and any supporting qualification or mapping data used to establish controlled areas, particularly when specific temperature ranges are declared on product labels. 

Additional information regarding HVAC zoning, water system monitoring, and other environmental controls provides further insight into how the site maintains a controlled environment. The equipment list should outline the current calibration and preventive maintenance status of critical equipment. Summaries of electronic systems such as ERP, QMS, or LIMS platforms should also describe access controls, audit trail capabilities, and backup practices, supporting Health Canada’s expectations for data integrity and electronic record management. 

GMP Evidence Required for NHP Site Licence Renewal 

The GMP evidence section forms the technical foundation of the renewal package and gives Health Canada a clear picture of how the site applies GMP requirements in daily operations. At this stage, the focus is on showing that the site maintains controlled procedures, keeps current documentation, and retains executed records that reflect actual practice. Rather than reviewing individual SOPs or record types in isolation, Health Canada looks for cohesive evidence that the quality system is active, consistent, and aligned with the activities authorized under the site licence. 

Internal audit results and validation summaries further support this assessment by demonstrating how the site evaluates its own compliance and maintains control of equipment, systems, and operational environments. Importers must also provide foreign-site GMP documentation to demonstrate oversight across the broader supply chain. Together, these elements create the baseline from which a site demonstrates ongoing GMP compliance. The next section outlines how licence holders can present this evidence effectively during renewal. 

How to Demonstrate GMP Compliance During Site Licence Renewal

Demonstrating GMP compliance during renewal requires documentation that reflects actual day-to-day operations. Records must show how the site manufactures, tests, stores, and releases product in accordance with Part 3 GMP, and they should present a clear, consistent picture of how the quality system functions throughout the licensing period. 

GMP Documentation and Record Requirements 

Master production documents must describe formulas, processing steps, yield ranges, and in-process checks. Executed batch records are expected to align with these documents and provide complete traceability, including deviations, investigation outcomes, and QA release decisions.  

Change control files should illustrate how the site evaluates risks associated with equipment changes, supplier changes, or procedural updates, while supplier qualification files and Certificates of Analysis (COA) must align with approved specifications. Stability programs must include supporting data that justifies expiry dating and storage conditions. Records related to sanitation, calibration, pest management, and environmental monitoring further contribute to Health Canada’s assessment of overall site control. 

Audit Expectations for NHP Site Licence Renewal 

Internal audits provide evidence of how the site assesses its own compliance and addresses identified issues. Findings should be risk-ranked and linked to corrective actions with documented follow-up. Importers must also present GMP evidence for all foreign sites involved in regulated activities. Health Canada places considerable weight on unredacted audit reports, as these documents provide a clear view of a foreign site’s compliance posture and the adequacy of oversight arrangements. 

Personnel and Training Requirements 

The renewal package must show that personnel remain qualified to carry out their assigned duties. Training records should correspond to specific job tasks and include annual GMP refreshers, method qualifications, and retraining following SOP revisions. Health Canada also reviews the QAP’s credentials and release authority to confirm that appropriate oversight is maintained for all regulated activities. 

Common Issues That Delay NHP Site Licence Renewal 

Delays in the renewal process often stem from gaps in documentation or inconsistencies within the submission. Identifying these issues early helps licence holders prepare a stronger package and reduces the likelihood of additional information requests. 

Incomplete or Inaccurate Renewal Packages 

Renewal packages that lack foreign-site documentation, updated SOPs, or consistent site information frequently lead to requests for clarification. Submitting summaries in place of executed records can also prompt questions, as Health Canada expects evidence that demonstrates active use of GMP procedures rather than theoretical controls. 

Weak GMP Evidence 

GMP records must reflect the period leading up to renewal. Missing or inconsistent entries in cleaning logs, calibration certificates, deviation files, or environmental monitoring records may raise concerns about the continuity of site controls. For importers, insufficient foreign-site oversight remains a common reason for delays, particularly when audit findings or qualification status are outdated or incomplete. 

Outdated Procedures or Insufficient Change Control 

When procedures do not align with current practice, or when training records and change control files lack the necessary updates, Health Canada may question whether operational changes have been appropriately assessed and documented. These issues often result in further follow-up and may extend the renewal timeline until adequate evidence is provided. 

NHP Site Licence Refusal or Suspension 

Health Canada may refuse or suspend a site licence when renewal documentation does not demonstrate continued compliance with the Natural Health Products Regulations. Understanding the circumstances that lead to these outcomes helps licence holders prepare corrective actions and respond effectively to regulatory findings. 

Reasons for NHP Site Licence Refusal 

Refusal generally occurs when critical elements of the renewal package are incomplete, outdated, or inconsistent with current site operations. Missing SOPs, gaps in training records, and absent or outdated calibration or foreign-site audit documentation are common contributors. Data integrity concerns, including inconsistent entries or unclear record histories, may also influence Health Canada’s decision if they suggest that the site’s controls are not functioning as described. 

NHP Site Licence Suspension Criteria 

Suspension is reserved for situations where Health Canada identifies a potential risk to health or evidence of a significant breakdown in GMP controls. This may arise from contamination events, falsified or unreliable data, or the site’s refusal to provide access to required records during an inspection. To regain licence status, sites are typically required to complete a corrective action plan that addresses the root causes of the findings, updates relevant procedures, and provides supporting evidence that compliance has been restored. 

How to Avoid Site Licence Renewal Delays 

Sites that maintain accurate and current documentation throughout the licensing cycle are in the strongest position for a smooth and timely renewal. Keeping a standing file that includes up-to-date SOPs, validation summaries, internal audit results, training matrices, and foreign-site documentation reduces the need for last-minute updates. Many organizations also conduct a pre-submission check to confirm that all addresses, activities, and supporting records are consistent across the renewal package. The following preparation strategies can further support an efficient renewal process. 

Conduct an Internal Pre-Renewal Audit 

Performing an internal audit several months before the renewal date allows the site to identify gaps in GMP records, documentation, or training files while there is still sufficient time to correct them. This step helps ensure that executed records are complete; deviations are closed and change control files reflect current operations. By identifying issues early, sites avoid preventable requests for clarification during Health Canada’s review. The benefit of a pre-renewal audit is a cleaner submission that reflects an active quality system and reduces the likelihood of administrative delays.

Verify Foreign-Site Evidence Well in Advance 

For importers, foreign-site GMP documentation is often the most time-sensitive component of the renewal package. Confirming that GMP certificates, audit reports, and quality agreements are current well before the renewal deadline helps avoid situations where external partners cannot provide updated records quickly. Early verification ensures that the renewal package aligns with the activities listed on the site licence and that Health Canada has clear evidence of supply-chain oversight. This preparation step minimizes interruptions caused by outdated or incomplete foreign-site information. 

Maintain a Renewal-Ready Document Set 

Establishing a renewal-ready document set that is updated throughout the licensing cycle greatly reduces the workload at the time of renewal. This includes keeping SOPs current, maintaining complete training matrices, updating validation summaries, and ensuring calibration and environmental monitoring records are available for the entire period under review. When documentation is maintained continuously, sites spend less time assembling evidence and more time confirming accuracy. The benefit is a streamlined submission that demonstrates year-round GMP control rather than last-minute compilation. 

Final Remarks

A successful NHP site licence renewal depends on documentation that is organized, current, and consistent with day-to-day operations. Facilities that maintain accurate records, monitor their quality systems throughout the licensing cycle, and update procedures as operations evolve are well positioned for a smooth renewal. This proactive approach strengthens GMP compliance, reduces the likelihood of delays, and supports uninterrupted market access in alignment with Health Canada’s expectations for regulated sites.

Looking for Support with Your Upcoming Site Licence Renewal? 

If your site is approaching its renewal window and you would benefit from a structured pre-renewal review, SNI can assist with assessing GMP records, confirming eligibility, and preparing the documentation required for a complete submission. Connect with our regulatory team to ensure your next renewal is accurate, timely, and aligned with Health Canada’s expectations. 

⬇️ Send us a request to learn more about labelling solutions

FAQ 

What happens after I submit my renewal package?

Once Health Canada receives a renewal submission, it undergoes an administrative completeness check. If the file meets the basic submission requirements, the NNHPD issues an Acknowledgement of Application Letter confirming that the renewal has entered the review queue. This acknowledgement marks the start of Health Canada’s service-standard timelines. 

What qualifies as pre-cleared GMP evidence, and how is it different from a QAR? 

Pre-cleared GMP evidence refers to valid, current GMP certificates issued by a qualified authority such as the FDA, EMA, MHRA, TGA, or other regulators recognized by Health Canada. When acceptable certificates are available for every site listed on the licence, the renewal can follow the 30-day review pathway. A QAR is required when pre-cleared GMP certificates are not available, or when the site relies on its own GMP program rather than a foreign regulator’s inspection. 

When do I need to submit an amendment instead of a renewal? 

Changes that affect ownership, site address, licensed activities, or core site details require a site licence amendment. These changes must be approved by Health Canada before the new activities are implemented and before submitting a renewal. Minor administrative updates that do not impact the licence scope, such as QAP contact updates, can typically be addressed through a notification. 

How long must I keep GMP records for renewal purposes? 

Under the Natural Health Products Regulations, records must be retained for at least one year after the product’s expiry date or three years from the date of sale, whichever is later. Because Health Canada may review executed records from throughout the retention period during renewal, missing or incomplete records often result in delays or requests for clarification. 

Does Health Canada always meet the posted service standards for renewal reviews? 

While Health Canada aims to meet its service standards, review timelines may extend beyond the published targets when files are complex or when review capacity is affected by volume. For this reason, licence holders are encouraged to prepare renewal materials well in advance of the expiry date and ensure that supporting evidence is complete, consistent, and current.

---

✷ The content on this website, including information presented in this post, is provided for general informational purposes only and does not constitute legal, regulatory, or professional advice. While efforts are made to ensure accuracy, laws and regulations vary by jurisdiction and may change over time. Readers should not rely on this information as a substitute for advice from qualified legal or regulatory professionals. We disclaim any liability for actions taken based on this content, and users are encouraged to seek guidance specific to their circumstances.